CXCL9 抗体
(gamma-Interferon-Induced Monokine (CXCL9))
The function of this gene has not been specifically defined\; however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines. [provided by RefSeq, Jul 2008].
Recommended next Filters:
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CXCL9 抗体 (N-Term) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Fluoro594) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Fluoro594) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (APC) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (APC) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Fluoro488) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Fluoro488) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (N-Term) (Fluoro647) | 人 | 兔 Polyclonal |
|
|
|
| CXCL9 抗体 (AA 23-125) (Fluoro647) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 23-125
筛选 1 个已启用筛选
Latest Publications for our CXCL9 抗体
: "HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy." in: Oncoimmunology, Vol. 8, Issue 1, pp. e1512942, (2019) (PubMed).
: "CXCL9 regulates acetaminophen-induced liver injury via CXCR3." in: Experimental and therapeutic medicine, Vol. 18, Issue 6, pp. 4845-4851, (2019) (PubMed).
: "The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks." in: PLoS ONE, Vol. 13, Issue 11, pp. e0207593, (2018) (PubMed).
: "Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation." in: Laboratory animal research, Vol. 34, Issue 1, pp. 1-10, (2018) (PubMed).
: "Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia." in: Archives of dermatological research, Vol. 309, Issue 4, pp. 315-321, (2017) (PubMed).
: "Interferon-γ Released by Activated CD8(+) T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves." in: The American journal of pathology, Vol. 187, Issue 6, pp. 1413-1425, (2017) (PubMed).
: "CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer." in: British journal of cancer, Vol. 115, Issue 5, pp. 553-63, (2016) (PubMed).
: "Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages." in: Journal of hepatology, Vol. 63, Issue 4, pp. 905-16, (2016) (PubMed).
: "Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan." in: Oncology reports, Vol. 33, Issue 5, pp. 2151-60, (2015) (PubMed).
: "CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment." in: Scientific reports, Vol. 5, pp. 15948, (2015) (PubMed).
: "CXCL9 regulates acetaminophen-induced liver injury via CXCR3." in: Experimental and therapeutic medicine, Vol. 18, Issue 6, pp. 4845-4851, (2019) (PubMed).
: "The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks." in: PLoS ONE, Vol. 13, Issue 11, pp. e0207593, (2018) (PubMed).
: "Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation." in: Laboratory animal research, Vol. 34, Issue 1, pp. 1-10, (2018) (PubMed).
: "Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia." in: Archives of dermatological research, Vol. 309, Issue 4, pp. 315-321, (2017) (PubMed).
: "Interferon-γ Released by Activated CD8(+) T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves." in: The American journal of pathology, Vol. 187, Issue 6, pp. 1413-1425, (2017) (PubMed).
: "CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer." in: British journal of cancer, Vol. 115, Issue 5, pp. 553-63, (2016) (PubMed).
: "Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages." in: Journal of hepatology, Vol. 63, Issue 4, pp. 905-16, (2016) (PubMed).
: "Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan." in: Oncology reports, Vol. 33, Issue 5, pp. 2151-60, (2015) (PubMed).
: "CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment." in: Scientific reports, Vol. 5, pp. 15948, (2015) (PubMed).
Aliases for CXCL9 抗体
C-X-C motif chemokine ligand 9 (CXCL9) 抗体chemokine (C-X-C motif) ligand 9 (Cxcl9) 抗体
C-X-C motif chemokine ligand 9 (Cxcl9) 抗体
BB139920 抗体
CMK 抗体
crg-10 抗体
Humig 抗体
MIG 抗体
Mig 抗体
MuMIG 抗体
SCYB9 抗体
Scyb9 抗体
您还需要查找其他产品吗？
You are here:
